Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.
Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K, Hunt M, Kessler M, Lawton CA, Mayo C, Michalski JM, Mutic S, Potters L, Rose CM, Sandler HM, Sharp G, Tomé W, Tran PT, Wall T, Zietman AL, Gabriel PE, Bekelman JE. Efstathiou JA, et al. Among authors: zietman al. J Oncol Pract. 2013 May;9(3):e90-5. doi: 10.1200/JOP.2013.001003. J Oncol Pract. 2013. PMID: 23942508 Free PMC article.
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences.
Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM. Shipley WU, et al. Among authors: zietman al. Semin Radiat Oncol. 2005 Jan;15(1):36-41. doi: 10.1016/j.semradonc.2004.07.008. Semin Radiat Oncol. 2005. PMID: 15662605 Review.
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Kupelian P, et al. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):415-9. doi: 10.1016/j.ijrobp.2004.05.018. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667961
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL. Horwitz EM, et al. Among authors: zietman al. J Urol. 2005 Mar;173(3):797-802. doi: 10.1097/01.ju.0000152556.53602.64. J Urol. 2005. PMID: 15711272
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D. Kupelian P, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. doi: 10.1016/j.ijrobp.2005.03.029. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15925452
366 results